Log in

NYSE:BAX - Baxter International Stock Price, Forecast & News

$83.96
+0.45 (+0.54 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$83.18
Now: $83.96
$84.04
50-Day Range
$76.39
MA: $80.53
$83.97
52-Week Range
$61.40
Now: $83.96
$89.93
Volume1.84 million shs
Average Volume2.20 million shs
Market Capitalization$42.87 billion
P/E Ratio27.53
Dividend Yield1.06%
Beta0.98
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.66 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$42.87 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, November 19th. Investors of record on Friday, December 6th will be paid a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Thursday, December 5th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International declared that its Board of Directors has approved a share buyback plan on Tuesday, November 13th 2018, which permits the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 6.1% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) released its quarterly earnings data on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. The firm's revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.64 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Baxter International.

What price target have analysts set for BAX?

13 brokerages have issued 12 month target prices for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $90.08 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

News headlines about BAX stock have been trending positive recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Baxter International earned a news impact score of 3.0 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Baxter International.

Are investors shorting Baxter International?

Baxter International saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 5,490,000 shares, a drop of 16.9% from the September 30th total of 6,610,000 shares. Based on an average trading volume of 2,830,000 shares, the days-to-cover ratio is presently 1.9 days. Currently, 1.1% of the company's stock are short sold. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Verizon Communications (VZ), Endologix (ELGX), Honeywell International (HON), AT&T (T), Micron Technology (MU) and Home Depot (HD).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (4.74%), Third Point LLC (3.30%), Veritas Asset Management LLP (1.25%), California Public Employees Retirement System (0.74%), Voya Investment Management LLC (0.59%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Veritas Asset Management LLP, Man Group plc, State of New Jersey Common Pension Fund D, Voya Investment Management LLC, First Trust Advisors LP, Alberta Investment Management Corp and Stifel Financial Corp. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which institutional investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Kornitzer Capital Management Inc. KS, Nomura Holdings Inc., California Public Employees Retirement System, Teacher Retirement System of Texas, Squarepoint Ops LLC, Dalton Greiner Hartman Maher & Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $83.96.

How big of a company is Baxter International?

Baxter International has a market capitalization of $42.87 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  636 (Vote Outperform)
Underperform Votes:  559 (Vote Underperform)
Total Votes:  1,195
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel